Cleared Traditional

K914180 - DESERET FLOW RESTRICTION VALVE

K914180 is an FDA 510(k) clearance for DESERET FLOW RESTRICTION VALVE, manufactured by Becton Dickinson Vascular Access, Inc.. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 233-day FDA review.

K914180 · Becton Dickinson Vascular Access, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1992
Decision
233d
Days
Class 2
Risk

K914180 is an FDA 510(k) clearance for the DESERET(R) FLOW RESTRICTION VALVE. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Becton Dickinson Vascular Access, Inc. (Sandy, US). The FDA issued a Cleared decision on May 8, 1992 after a review of 233 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Becton Dickinson Vascular Access, Inc. devices

FDA 510(k) Submission Details - K914180

510(k) Number K914180 FDA.gov
FDA Decision Cleared Substantially Equivalent - De Novo Granted (SEKD)
Date Received September 18, 1991
Decision Date May 08, 1992
Days to Decision 233 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d slower than avg
Panel avg: 129d · This submission: 233d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 299
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K914180.
SAFEDWEL(R) CENTRAL VENOUS CATHETER
K914528 · Becton Dickinson Vascular Access, Inc. · Oct 1992
SAFE-DWELL PLUS CENTRAL VENOUS CATHETER
K921270 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1992
SAFE-PICC PERIPHERALLY INSERTED CENTRAL VENOUS CAT
K920828 · Menlo Care, Inc. · Aug 1992
E-Z SET/MINICATH INFUSION SETS
K920635 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1992
LANDMARK MIDLINE CATHETER
K920028 · Menlo Care, Inc. · Mar 1992
VERSACATH MAINLINE CENTRAL VENOUS CATHETER
K920128 · Menlo Care, Inc. · Mar 1992